- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Sectors
Lycia Pharmaceuticals rakes in $70m
Eli Lilly and Alexandria Real Estate Equities are among the investors in a round that took the protein drug developer’s total funding to over $150m.
Sep 13, 2021Exscientia explores Nasdaq IPO
Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.
Sep 13, 2021HomeLane spruces up $50m series E
HomeLane has now taken in over $104m of funding since it was founded, including a series E round backed by Pidilite Group.
Sep 13, 2021Corporates swoop in for Skydweller’s $40m series A
Palantir and Leonardo have helped solar-powered aircraft technology developer Skydweller fill out its oversubscribed series A funding round.
Sep 13, 2021Prism BioLab appraises series C round
The Ohara Pharmaceutical-backed small-molecule therapy developer has secured $11.8m from new and returning investors.
Sep 13, 2021Riverfield flows with fresh funding
Toray Engineering has returned to back a $27.3m round for the surgical robot developer, investing alongside Dai-ichi Life and Medipal Innovation.
Sep 13, 2021Analysis: PayPal pays $2.7bn to Paidy
PayPal is to purchase its portfolio company Paidy, a consumer finance service provider. Paidy is part of the wider payment tech space, which has seen an increasing number of exits since last year.
Sep 13, 2021Daily Deal Round Up: September 10, 2021
Myeg returned for augmented reality technology developer HiScene's $41.6m series C-plus round while celiac disease drug developer Calypso Biotech hiked a corporate-backed round to over $33m.
Sep 10, 2021Daily deal net: September 10, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 10, 2021Penn produces iEcure with $50m
Based on technology at University of Pennsylvania, iEcure has launched to commercialise gene therapies initially for liver disorders and an option to license more assets.
Sep 10, 2021Snyk snaps up $530m
Atlassian Ventures and Salesforce Ventures have returned to back a primary and secondary series F round for the app security platform developer that included Koch Strategic Platforms.
Sep 10, 2021Varo Bank cashes in with $510m round
The Progressive-backed neobank has secured the fresh funding at a reported $2.5bn valuation, seven months after it closed a $63m round.
Sep 10, 2021Featured Content
The CVC Funding Round DatabaseRealtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.The CVC Funding Round Database
Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.
CVC DirectoryFull details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.CVC Directory
Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
